Canertinib dihydrochloride
Canertinib dihydrochloride (PD-183805 dihydrochloride) is an orally active quinazoline-based hydrochloride salt. It functions as a potent, irreversible pan-ErbB tyrosine kinase inhibitor, demonstrating antineoplastic and radiosensitizing properties in preclinical cancer research, including studies on breast and lung carcinoma models.
Product Specifications
CAS Number
289499-45-2
Product Name Alternative
PD183805, PD-183805, PD183805 Dihydrochloride, PD-183805 dihydrochloride, PD 183805, PD 183805 Dihydrochloride, HER2/ErbB2, EGFR, CI 1033, CI 1033 Dihydrochloride, CI1033, CI-1033, CI1033 Dihydrochloride, CI-1033 dihydrochloride
Field of Research
Cardiovascular Research, Infectious Disease & Virology, Signal Transduction
Purity
99.13% (May vary between batches)
Solubility
DMSO:59.38 mg/mL (106.25 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.58 mM)
Smiles
Cl.Cl.Fc1ccc (Nc2ncnc3cc (OCCCN4CCOCC4) c (NC (=O) C=C) cc23) cc1Cl
Molecular Formula
C24H27Cl3FN5O3
Molecular Weight
558.86
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
18777121 3x 1.0µg DNA
DYRK2 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details 
orb2594960 100 µg
HLA-DR/HLA-DRA/HLA Mouse Monoclonal Antibody (Cy3)
Sign In for Pricing
View Details 
